Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 - Test2 - elhamkhani - TriplyDB

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

http://www.wikidata.org/entity/Q28382823

about

Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level Melanoma, Darwinian medicine and the inner world Redox-directed cancer therapeutics: molecular mechanisms and opportunities Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo Mitochondria, cholesterol and cancer cell metabolism Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications Cancer drug resistance: redox resetting renders a way Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance Hormesis: Decoding Two Sides of the Same Coin The mutational landscape of hepatocellular carcinoma Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention Hydrogen peroxide - production, fate and role in redox signaling of tumor cells The role of peroxiredoxin II in chemoresistance of breast cancer cells Oxidative stress responses and NRF2 in human leukaemia Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage Role of p62/SQSTM1 in liver physiology and pathogenesis Nrf2 mediates redox adaptations to exercise Epigenetic regulation of Keap1-Nrf2 signaling DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma Nuclear Factor-Erythroid-2-Related Factor 2 in Aging and Lung Fibrosis Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis Stress-activated cap'n'collar transcription factors in aging and human disease Application of proteomics to soft tissue sarcomas Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway Intronic DNA elements regulate Nrf2 chemical responsiveness of the human microsomal epoxide hydrolase gene (EPHX1) through a far upstream alternative promoter Progress and prospects of reactive oxygen species in metal carcinogenesis The complexity of the Nrf2 pathway: beyond the antioxidant response Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism p62 links autophagy and Nrf2 signaling The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?RETRACTED: Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis Nrf2 signaling and cell survival Oxidative Stress and Response to Thymidylate Synthase-Targeted Antimetabolites Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders

P2860

Q24323175-DE7A4316-80BD-4F55-ACEB-9B3FEEB7C50F Q24627770-42229DAF-F333-4C7E-ADD6-3BE7FE37A0FA Q24645584-26B70F0C-8EB4-4A7B-9B74-FFAA1C5C08F7 Q24646029-58AB4229-B3D7-422E-9AFF-E5B1A3515F1D Q26741062-1A193DA6-F25C-4292-8541-363BD9B7BB39 Q26741708-0544D1BB-23A2-42B7-B955-97DFC467966E Q26747274-40A3D969-37EC-4590-8C72-ABC74E162EDE Q26750753-0C1DE6BC-FDA0-4CED-9174-BF3D2ACEEB7B Q26765805-5FBDCD82-79C1-4857-BFEE-6B33F7C0E631 Q26772298-8B6809E7-85FB-4455-8C8D-1BABD4876BE3 Q26773354-827E9705-F345-4B32-8B80-FE0CB0DC4A10 Q26777478-752CDE4C-17CB-474B-A9A6-FE33EE755601 Q26778356-2BA30F8E-FFFD-4EA9-9DBC-DF20F3FEEA3E Q26787065-ECF22DCB-3654-43C3-A9CB-63252CBDEDAD Q26824860-3ADF99F3-9B67-4091-AAEE-843CDCC7F141 Q26864239-8E5AFC77-A055-4F54-9684-A4024C6CBE0C Q26995211-47E67712-D2F5-4F3E-A6B5-5A946932C47D Q27010478-8DD12F98-2628-42B8-A435-ADA153E351BD Q28072747-3DBA0DFB-904B-4964-9F6C-0630DFCD6046 Q28084220-B0A61ECF-7707-49E5-B1E8-69626BDEDB45 Q28297100-AC1C4688-1838-422F-B512-5AD4E1EE6732 Q28383171-38C12351-D283-4C67-A041-3787599DB79D Q28383226-7A892E30-3ED9-4E0C-BA97-222F2E97202B Q28384783-20391C51-9671-4F22-9BAF-0D2CA12DB2E9 Q28385995-0C105B97-78EB-4870-A574-9C5B3F2CA0DD Q28386244-CBB38B3C-3441-438E-B5A5-5F357EACF3C2 Q28386384-96EC0216-A3B0-4A80-BB3A-AED33B47952C Q28386991-5673A807-2800-437A-84E2-7860EC2659FE Q28388934-D44A2C10-6E45-464B-9B7E-55F46ED45585 Q28389296-3FABC8A0-6DFE-4128-A04D-6CCEB4DDC3DE Q28391385-766272F7-4352-497E-8CF7-8F9E44423EFC Q28391489-4541165F-48E4-4643-A902-35B45CD01AC0 Q28392347-99B339DA-8015-47C4-93EA-A1BBE3CB1A74 Q28392820-CEB61B0C-148C-4426-9FB0-0DF2E6C33EE7 Q28393090-21AA25BC-C0B6-4FF4-AC82-BC289701781A Q28393907-9131605C-1560-4FFE-8B2E-B980278650A6 Q28394210-5AE445F1-EF2E-4EBC-B647-54F25F92F069 Q28394674-A720B2C6-EF55-4BAE-8EB9-8B3F7646DA1A Q28394732-CC786E2D-B7E0-42C0-9C2D-EFE430CC01EC Q28395641-119FC82D-C88A-464C-AEB0-3E3DAF6CD5AD

P2860

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

http://www.wikidata.org/entity/Q28382823

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@ast

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@en

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@nl

type

label

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@ast

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@en

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@nl

prefLabel

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@ast

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@en

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@nl

P1433

Q28382823-E1A37765-035B-45A0-8116-7C7CC49EB476

P1476

Q28382823-61ACBE9F-9610-4BD1-8E99-00A58831F6CE

P2093

Q28382823-2B28E641-43AB-4A02-A80F-E58B68883067

Q28382823-2DC0F1CE-00C3-407E-A085-732E2EA6D431

Q28382823-32EC75C6-508A-4695-8697-080CC9F121DE

Q28382823-4D49AB47-2FC8-4A18-A6E5-E39BE231F26D

Q28382823-4E3E11EF-28E4-44DC-9963-4FD86CA7280E

Q28382823-5F3B7EB6-C3A6-4B8C-A788-CE8E2DC21ADC

Q28382823-5F656914-BAD9-4535-A1EF-DE69B831337A

Q28382823-9081D71E-F93C-42AF-8AD2-A0C15154A26F

Q28382823-CE32A818-599D-4D24-A49F-243845EDFAD5

Q28382823-F68560F0-61B3-48ED-BE58-6E32C40FEF77

P2860

Q28382823-10436C05-3E41-413A-AAA7-E05B83035A57

Q28382823-1097CF22-8B17-446B-A2AF-AF41DEF85F15

Q28382823-11DA2671-9D16-4449-BF5A-38E92CBED3D5

Q28382823-11F37849-4753-4560-83FF-C19C6604A184

Q28382823-11F9B2ED-7B27-4182-8768-B8AFEEBBF6E8

Q28382823-18117A37-032E-4D16-990C-FF473A937BFA

Q28382823-1CADCDF9-3B6D-4E89-8DF3-FF1CE03A077A

Q28382823-215AE696-1F52-4F0F-9B7B-EC9BAA50996E

Q28382823-24F5E669-6433-4469-B5C5-570E63BEF01A

Q28382823-2B8126A5-E78B-4BAC-9B28-4F477D9CC144

P304

Q28382823-B482F8B0-E6CF-49F7-9238-C62F90A51E33

P31

Q28382823-BC0346A0-DE44-4A97-BA6C-F329E42E263E

P3181

Q28382823-13EF6090-2BFA-400E-B003-0CECE32A67C6

P356

Q28382823-59CE2C25-02CD-44F4-A202-3D7AD2E023AB

P407

Q28382823-DED6067C-A6A6-48F9-87DA-C23CD065528B

P433

Q28382823-E3D7235E-F24E-42E0-9EDE-D2D3765C6DA5

P478

Q28382823-7E805017-96AE-40FF-8D73-26ADD34FDF1B

P50

Q28382823-C057D8CC-C221-4B55-AFB0-3B92D39B9A0A

P577

Q28382823-ADC3B543-1B07-4F7E-8DB0-AC2CA055D031

P5875

Q28382823-83AA733C-4520-4FE9-8523-BC3F911CEA6B

P698

Q28382823-48B72906-1B77-4901-A92E-B72B34A3CACE

P921

Q28382823-9AF05ADC-9C57-4846-8309-4111B432B891

P932

Q28382823-2C32D175-036A-47F8-8371-028B4F3F5E60

P3181

P356

P1433

P1476

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

@en

P2093

Donna D Zhang

http://www.w3.org/2001/XMLSchema#string

Georg T Wondrak

http://www.w3.org/2001/XMLSchema#string

Nicole F Villeneuve

http://www.w3.org/2001/XMLSchema#string

Pak Kin Wong

http://www.w3.org/2001/XMLSchema#string

Shirley Zhang

http://www.w3.org/2001/XMLSchema#string

Weimin Chen

http://www.w3.org/2001/XMLSchema#string

Wenxin Zheng

http://www.w3.org/2001/XMLSchema#string

Xiao-Jun Wang

http://www.w3.org/2001/XMLSchema#string

Xiaofang Yi

http://www.w3.org/2001/XMLSchema#string

Yanjie Li

http://www.w3.org/2001/XMLSchema#string

P2860

Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray

Mechanistic studies of the Nrf2-Keap1 signaling pathway

Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China

An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen

Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2

P304

1235-1243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1648996

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/CARCIN/BGN095

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5440026

http://www.w3.org/2001/XMLSchema#string

P698

18413364

http://www.w3.org/2001/XMLSchema#string

P921

P932

3312612

http://www.w3.org/2001/XMLSchema#string